The efficacy of intravenous atropine in abolishing the nasal irritation of chlormethiazole was assessed. Forty elderly patients undergoing transurethral resection of prostate under spinal anaesthesia were studied. One ml of either atropine sulphate (0.6 mg) or normal saline was administered intravenously in a double-blind fashion 10 minutes prior to infusion of 0.8% chlormethiazole edisylate. A loading infusion of 5 ml.min-1 of the chlormethiazole solution was followed by a variable rate of infusion in order to maintain a predetermined state of sedationi.e. where the patient lapsed into sleep but was easily awakened to obey commands. Sneezing was the commonest side-effect occurring in 45 % and 70% of patients in atropine and saline groups respectively. This was not effectively abolished by IV atropine in incremental doses of 0.6 mg up to 1.8 mg. Because of the sneezing and restlessness, four patients in the atropine group required general anaesthesia to improve operating conditions. These side-effects of chlormethiazole may limit its use as a sedative for surgery in this elderly age group.
Desirable properties of intravenous sedative agents should include easy control of the clinical state of sedation throughout surgery and rapid, lucid recovery after surgery. These clinical effects are related to the pharmacokinetic properties of high clearance, short elimination half-life and extensive body redistribution. Chlormethiazole has both favourable pharmacodynamic and pharmacokinetic properties l -3 and has attracted attention as an intravenous sedative, as being ·F.F.A.R.A.C.S., Lecturer. "M.Se., Ph.D., Reader.
tM.D., F.F.A.R.A.C.S., Professor and Chairman. useful in supplementing regional anaesthesia for surgery. 4, 5 An ideal sedative agent should be tolerably free of adverse effects. Chlormethiazole, unfortunately, has been associated with a high incidence of nasal irritation, as high as 100070 in unpremedicated subjects. 2 ,3,6 Kristoffersen et al. 7 did not encounter any nasal irritation in patients premedicated with morphine and scopolamine, and pre-treated with intravenous atropine prior to chlormethiazole infusion. This suggests that the antismuscarinic effect may play a part in abolishing these nasal sideeffects, allowing greater freedom in the use of chlormethiazole. A double-blind study, therefore, was undertaken to establish whether atropine was useful in preventing or abolishing the nasal irritation caused by chlormethiazole.
MATERIALS AND METHODS
Forty fit and healthy patients undergoing transurethral resection were studied. Their ages ranged from 51 to 90 years and their weights from 46 to 91 kg. All were non-smokers with no known history of allergy, hay fever or sinusitis. Any patient with known cardiorespiratory illness was excluded. Patients were premedicated with oral diazepam 10 mg two hours preoperatively. Spinal analgesia to T 10 level was achieved with 0.50/0 heavy cinchocaine hydrochloride. Infusion of intravenous electrolyte solution was started at a rate of 5 ml.kg-I bodyweight over 10 minutes prior to the spinal injection.
One ml of either atropine sulphate 0.6 mg or 0.9% normal saline* was given intravenously 10 minutes before the start of the chlormethiazole infusion, using a double-blind method and random selection of patients. Chlormethiazole edisylate (HeminevrinR) was administered as 0.8% solution via a 100 ml burette as a side-drip, at an initial loading rate of 5 ml.min -I until the patient achieved a predetermined state of sedation -i.e. the patient lapsed into a sleep-like state yet awoke easily to obey commands and to converse. The drip rate of chlormethiazole then was adjusted to maintain this state throughout surgery. Clinical observations included blood pressure, heart rate, finger plethysmography, ECG and level of sedation. Indirect questioning (such as "does your nose feel any different from normal?") was made thoughout the chlormethiazole infusion. If a patient sneezed, atropine sulphate 0.6 mg was administered intravenously at 5-minute intervals until the patient stopped sneezing or a maximum dose of 1.8 mg had been given. General anaesthesia with halothane was instituted if sneezing was not controlled and/or the restlessness disturbed surgery. The code for atropine/saline ampoules was broken only after the study was completed.
RESULTS
The physical characteristics of the patients in the two groups were not different ( Table 1 ).
*Identical ampoules of atropine solution and saline were made by the Pharmacy Department of Flinders Medical
Centre.
There were no significant differences (Student's t test) between the two groups with respect to loading periods, maintenance rates, total volumes of chlormethiazole infused nor duration of surgery. The frequency of side-effects is shown in Table 2 . The most common problem was sneezing, occurring in 45% and 70% patients in the atropine and saline groups respectively. Thirty-five per cent of patients in the atropine group and 30% in the saline group complained of nasal irritation during the loading phase of the infusion. This ranged from a hot peppery sensation to tingling or itchy feeling. General anaesthesia had to be administered to four patients in the atropine group because sneezing and restlessness rendered the operating conditions unfavourable. Intravenous atropine in incremental doses of 0.6 mg up to 1.8 mg did not consistently abolish the sneezing. Blood pressure decreased and heart rates increased comparably in both groups irrespective of atropine administration (Table 2) .
Chlormethiazole infusion provided excellent sedation for these patients. Patients in both groups lapsed into a sleep-like state when left undisturbed yet were easily awakened to converse and to obey commands, such as pressing onto swabs after blood sampling. This state was maintained easily by regulation of the maintenance drip rate. Corresponding venous blood chlormethiazole concentrations were 4.0 (SD 1.5) mg.l-I and 3.9 (SD 1.9) mg.l-I in the Side-effects and changes in vital signs. *IV atropine sulphate 0.6 mg given at 5 min intervals until sneezing stopped or a miximum of 1.8 mg had been given.
atropine and saline groups respectively, suggesting that there were no pharmacokinetic or pharmacodynamic drug interactions between chlormethiazole and atropine. All patients were completely amnesic commencing with the completion of the loading dose of chlormethiazole infusion and ending within minutes of entering the recovery room.
DISCUSSION
An increasing number of surgical procedures on elderly patients, such as transurethral resection of prostate, are being done under regional anaesthesia. Chlormethiazole infusion has been recommended to improve patient comfort, especially for this age group9 for basal sedation, thereby avoiding postoperative confusion. The present results have confirmed these and other reports of the clinical usefulness of chlormethiazole infusion. 4 ,5,9 However, nasal irritation was the commonest side-effect of chlormethiazole infusion (30-3511,10 incidence) and this has been reported previously. 2, 3, 4, 6, 9.10 Castleden et al. II commented that the oral preparation was not an ideal hypnotic for the young because of the high incidence (10011,10) of unpleasant nasal symptoms. In young, unpremedicated volunteer subjects receiving chlormethiazole infusion rates of 12 to 20 ml.min -I, all subjects experienced nasal congestion in the recovery period lasting 2-3 hours. 6 Marley and Ward 9 observed a 1211,10 incidence of sneezing in elderly unpremedicated patients reCeiVIng chlormethiazole infusion of 8 to 10 ml.min -I. The high incidence of nasal irritation and sneezing found in our study could have been related to the slow rate of infusion used, since Marley and Ward 9 found that this side-effect could be overcome by increasing the infusion rate. However, the possibility of pharmacologic control would seem to offer greater predictability. Since Kristoffersen et af.1 found no occurrence of nasal irritation with chlormethiazole infusion in patients receiving morphine and scopolamine premedication, together with intravenous atropine prior to chlormethiazole infusion, this suggested that the antimuscarinic effect may play a part in abolishing this side-effect.
Belladonna alkaloids inhibit secretions of the nose, mouth, pharynx and bronchi, and thereby dry the mucous membrane of the respiratory tract. This action is especially marked if there are excessive secretions. Excessive secretions caused by chlormethiazole infusion contribute to the coryza-like syndrome of sneezing and coughing. These side-effects not only are unpleasant to patients but also provide unfavourable operating conditions should patients sneeze or cough. Antisialogogues, such as scopolamine or atropine, may be postulated to reduce the incidence of these side-effects by drying the mucous membranes. Scopolamine is more potent in its action on the salivary and bronchial secretions compared with atropine, and would appear to be the more rational choice for this purpose. However, its effects on the eyes, causing mydriasis and cycloplegia, are more marked, and this can be unpleasant in patients undergoing and recovering from sedation. In addition, in the elderly patients, clinical doses of scopolamine occasionally cause delirium, confusion, or even hallucinations, arising from central ex citatory effects. In view of these problems with scopolamine in the elderly patients, we attempted to establish whether atropine, alone, could be equally effective.
Our double-blind study, however, clearly demonstrated that intravenous atropine per se did not influence the incidence of nasal symptoms from chlormethiazole infusion in this group of elderly patients. Neither did it stop the symptoms once they have occurred. While this may be another age-related response to atropine, analogous to age-related cardiovascular and central nervous system responses,12,13 it could be due to insufficient atropine reaching the receptor site after intravenous administration. Pharmacokinetic studies by Virtanen et al. 14 may support this hypothesis, since high atropine concentrations were shown to occur in human CSF after a single intramuscular dose of 0.015 mg.kg, -I but not after an intravenous dose of 0.01 mg.kg.-I Furthermore, after intravenous administration, a very rapid distribution phase (half-life 1-2 min) was also observed, suggesting a very rapid distribution of atropine out of well-perfused tissues and away from receptor end-organs. Intramuscuiar administration leads to a slowly increasing blood concentration l5 ,I6 with concurrent redistribution, possibly allowing more atropine to build up in the end-organs and exert greater effects. While our study indicated a failure of intravenous atropine to abolish nasal problems caused by chlormethiazole, in view of the above pharmacokinetic considerations, further study is warranted to establish whether intramuscular atropine is effective.
